NRAS and neoplasm: Different from KRAS and BRAF (V600E) mutation, none of the clinical characteristics, such as age, gender, tumor sites, histological type, differentiation, TNM stage, lymphovascular invasion, and perineural invasion, was associated with NRAS mutation.